127 related articles for article (PubMed ID: 7863231)
1. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects.
Jepsen S; Hansen AB
Scand J Clin Lab Invest; 1994 Nov; 54(7):543-7. PubMed ID: 7863231
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
[TBL] [Abstract][Full Text] [Related]
3. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
Korsan-Bengtsen K
Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
[No Abstract] [Full Text] [Related]
4. Vitamin K2 (Menaquinone-7) supplementation does not affect vitamin K-dependent coagulation factors activity in healthy individuals.
Ren R; Liu J; Cheng G; Tan J
Medicine (Baltimore); 2021 Jun; 100(23):e26221. PubMed ID: 34115006
[TBL] [Abstract][Full Text] [Related]
5. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
7. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
[TBL] [Abstract][Full Text] [Related]
8. The in vitro effect of N-acetylcysteine on prothrombin time in plasma samples from healthy subjects.
Pizon AF; Jang DH; Wang HE
Acad Emerg Med; 2011 Apr; 18(4):351-4. PubMed ID: 21496136
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
Mineo HK; Garabed RB
Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin.
Andrew M; Schmidt B; Mitchell L; Paes B; Ofosu F
Thromb Haemost; 1990 Feb; 63(1):27-30. PubMed ID: 2339359
[TBL] [Abstract][Full Text] [Related]
11. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
Peterson P; Gottfried EL
Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
[TBL] [Abstract][Full Text] [Related]
12. [Electra 600 d : results of a three year study (author's transl)].
Gouault-Heilmann M; Dumont MD; Caron N; Guiard AM
Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):179-85. PubMed ID: 704333
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
Martini WZ; Dubick MA; Wade CE; Holcomb JB
Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
[TBL] [Abstract][Full Text] [Related]
14. Somatotropin and somatostatin effects on vitamin K-dependent plasma coagulation factors.
Negrev N; Nyagolov Y; Stanchewa E
Eur J Pharmacol; 1995 Apr; 277(2-3):145-9. PubMed ID: 7493602
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PT, aPTT, and factor VII values obtained by concurrent sample collection by direct venipuncture and peripheral venous catheters.
Lindley C; Sawyer W; Haddon T; Meade J; Nolen J; Johansen L; Roberts H
Pharmacotherapy; 1994; 14(2):224-8. PubMed ID: 8197044
[TBL] [Abstract][Full Text] [Related]
16. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma.
Teng HW; Chen PM; Yang YH; Gau JP
Jpn J Clin Oncol; 2007 Aug; 37(8):609-14. PubMed ID: 17693643
[TBL] [Abstract][Full Text] [Related]
17. Properties of optical data from activated partial thromboplastin time and prothrombin time assays.
Braun PJ; Givens TB; Stead AG; Beck LR; Gooch SA; Swan RJ; Fischer TJ
Thromb Haemost; 1997 Sep; 78(3):1079-87. PubMed ID: 9308757
[TBL] [Abstract][Full Text] [Related]
18. Interactions of bexarotene (LGD1069, Targretin) with the coagulation system.
Hespel A; Mejdoubi-Charef N; Yous S; Courty J; Papy-Garcia D; Charef S
Cancer Chemother Pharmacol; 2011 Oct; 68(4):847-54. PubMed ID: 21229355
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats.
Soulban G; Labrecque G
Life Sci; 1989; 45(25):2485-9. PubMed ID: 2607889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
